12 Results for "

PSMA-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "PSMA-IN-1" in MCE Product Catalog:

Cat. No.: HY-149297
Target:  

PSMA

Research Areas:  

Cancer

PSMA-IN-1 (compound 23) is an inhibitor of PSMA with a Ki value of 2.49 nM. PSMA-IN-1 inhibits tumor growth with high selectivity and specificity in PSMA+ xenograft models. PSMA-IN-1 is a NIR probe (λEX: 620 nm; λEM: 670 nm) used for tumor disappearance. PSMA-IN-1 can be used for research on prostate cancer [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P10055A
Synonyms: PSMA-1 TFA
Target:  

PSMA

Research Areas:  

Cancer

PSMA targeting peptide TFA (PSMA-1 TFA) is a PSMA targeting peptide (GRFLTGGTGRLLRIS) and can be used for targeted delivery of glucose-regulated protein (GRP)-silencing siRNAs in PCa cells [1].
loading...
    loading...
Cat. No.: HY-158123
CAS No.: 2170653-14-0
Purity:  98.33%
Target:  

PSMA

Research Areas:  

Cancer

PSMA binder-1 is a ligand for PSMA and can be used to synthesize PSMA targeting molecule, such as Ac-PSMA-trillium .
loading...
    loading...
Cat. No.: HY-P991359
Synonyms: MEDI3726 antibody; ADCT-401 antibody

Target:  

PSMA ADC Antibodies

Research Areas:  

Cancer

Anti-FOLH1/PSMA Antibody (J591) (MEDI3726 antibody) is a human monoclonal antibody (mAb) targeting FOLH1/PSMA. Anti-FOLH1/PSMA Antibody (J591) can be used in Prostate cancer research [1].
loading...
    loading...
Cat. No.: HY-175229
CAS No.: 3066073-36-4
Target:  

PSMA

Research Areas:  

Cancer

PSMA ligand 1 (Compound 1c) is a PSMA ligand with an IC50 of 26.74 nM. The [ 18F]-labeled PSMA ligand 1 can serve as a PSMA PET tracer and is used in research on the diagnosis of prostate cancer [1].
loading...
    loading...
Cat. No.: HY-P10055
CAS No.: 2042750-71-8
Synonyms: PSMA-1
Target:  

PSMA

Research Areas:  

Cancer

PSMA-1 is a PSMA targeting peptide (GRFLTGGTGRLLRIS) and can be used for for targeted delivery of glucose-regulated protein (GRP)-silencing siRNAs in PCa cells. PSMA-1 is selected and polyarginine sequences R6 or R9 were added at the C terminus to generate the CTPs. FITC labeling of the peptide with an aminohexanoic acid (Ahx) linker at the N terminus produced FITC-PSMA-1,to track PSMA binding on PCa cells [1].
loading...
    loading...
Cat. No.: HY-139670
CAS No.: 2703051-77-6
Purity:  98.85%
Target:  

PSMA

Research Areas:  

Cancer

PSMA–DA1 may be a useful PSMA-targeting radiotheranostic agent.
loading...
    loading...
Cat. No.: HY-168757
CAS No.: 1423622-48-3
Target:  

PSMA

Research Areas:  

Cancer

PSMA precursor-1 is a precursor in the synthesis of prostate-specific membrane antigen (PSMA) ligands and fluorescent probes that have been used in the detection of PSMA in LNCaP and PC3 cells [1].
loading...
    loading...
Cat. No.: HY-P11310
Target:  

PSMA

Research Areas:  

Cancer

PSMA-1-SMCC is a selective binding agent targeting Prostate-Specific Membrane Antigen (PSMA). PSMA-1-SMCC is promising for research of targeted imaging for prostate cancer [1] .
loading...
    loading...
Cat. No.: HY-P991650

Target:  

PSMA

Research Areas:  

Cancer

MDX1201 is a humanized monoclonal antibody targeting PSMA1/7. MDX1201 conjugated with a fluorescent dye AlexaTM488 can be used as a probe for near-infrared fluorescence imaging (NIRF) imaging of prostate cancer [1].
loading...
    loading...
Cat. No.: HY-P11488
JR11-PEG3-DOTA-PSMA-03 (Compound 2) is an RDC-related compound containing the chelating agent DOTA (HY-W053583), the JR11 peptide (SSTR2 antagonist), and the PSMA ligand. JR11-PEG3-DOTA-PSMA-03 shows SSTR2-binding affinities and PSMA-binding affinities, with IC50 s of 94.0 nM, 81.8 nM, respectively. JR11-PEG3-DOTA-PSMA-03 can be radiolabeled with [ 68Ga]. [ 68Ga] radiolabeled JR11-PEG3-DOTA-PSMA-03 can be used in diagnostic studies of neuroendocrine differentiated prostate cancer [1].
loading...
    loading...
Cat. No.: HY-P11485
JR11-PEG3-HBED-CC-PSMA-03 (Compound 1) is an RDC-related compound containing the chelating agent HBED-CC, the JR11 peptide (SSTR2 antagonist), and the PSMA ligand. JR11-PEG3-HBED-CC-PSMA-03 shows SSTR2-binding affinities and PSMA-binding affinities, with IC50 s of 59.2 nM, 57.0 nM, respectively. JR11-PEG3-HBED-CC-PSMA-03 can be radiolabeled with [ 68Ga]. [ 68Ga] radiolabeled JR11-PEG3-HBED-CC-PSMA-03 can be used in diagnostic studies of neuroendocrine differentiated prostate cancer [1].
loading...
    loading...
  • 1